News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
NeonMind Engages KCSA Strategic Communications to Provide Public Relations and Investor Relations Services
NeonMind Biosciences Inc.
Red Light Holland Receives Patent Pending Status For 'Find Your Dose' Customization of Microdosing Kits Based on Biometric and Movement Data
Red Light Holland
MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics
Mind Medicine (MindMed)
World Renowned Physician Joins Core One Labs as Chief Medical Officer
Core One Labs Inc.
Mydecine Announces Partnership with LeadGen Labs
Mydecine Innovations Group
Evan Levine | Chairman & CEO, PsyBio Therapeutics
PsyBio Therapeutics
The Good Shroom Co Enters Into Private Labeling Agreement
The Good Shroom Co
Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol
Optimi Health
Numinus
Field Trip Health Ltd. Announces Opening of Psychedelic-Enhanced Therapy Center in Houston; Locations of Next 5 Field Trip Health Centers
Field Trip Health
Core One Labs Completes Milestone Acquisition of Akome Biotech
Core One Labs Inc.
Psyched Wellness Signs Supply Agreement For Amanita Muscaria
Psyched Wellness
Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities
Braxia Scientific Corp.
Tryp Therapeutics Partners with Fluence for Psychotherapy Design
Tryp Therapeutics
Mydecine Reports Full Year 2020 Financial Results and Provides Business Update
Mydecine Innovations Group
Professor David Nutt | DMT Stroke Consultant , Algernon Pharmaceuticals
Algernon Pharmaceuticals
Judy Blumstock | CEO & Founder, Diamond Therapeutics
Diamond Therapeutics
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.